Episode 12 of the “MedChat” podcast is provided in two parts to address provider compliance with guidelines of the Drug Enforcement Administration (DEA), as well as other safeguards when prescribing controlled substances.
Part One of the “DEA Provider Compliance” episode discusses the latest guidelines related to administrative aspects of prescribing controlled substances to avoid any compliance issues. It defines the role of the DEA, discusses key aspects of compliance relative to the practice setting, provides insight on important and recurring opioid risk areas and details practical strategies and tips to reduce opioid risks.
Part Two of the episode addresses common concerns for DEA compliance in practice and red flags for a DEA investigation.
Moderator Stephen P. Wright, M.D., medical director, pediatrics, with Norton Medical Group, speaks with Dennis Wichern, managing partner, Prescription Drug Consulting LLC, and a former DEA special agent-in-charge.
This activity has received financial support from Cardinal Health.
American Medical Association
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Norton Healthcare designates each of the two parts of this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HB1/Prescribing Controlled Substances
The Kentucky Board of Medical Licensure has approved the podcast “DEA Provider Compliance and Safe Guards: Part One” for .50 HB1 credit hours. ID# 0120-H.50-NHC1d.
Date of original release | February 2020
Course termination date | December 2020
Contact information | Center for Continuing Medical Education; (502) 446-5955 or firstname.lastname@example.org.
Listen to the Podcast Now
Access the “MedChat” podcast at NortonHealthcare.com/CME, from Apple Podcasts or from other podcast apps. Subscribe to the podcast and be the first to know when new episodes are available.